Dengue NS1 Antigen, IgM/IgG Antibody Dual
Igama lemveliso
HWTS-FE031-Dengue NS1 Antigen, IgM/IgG Antibody Dual Detection Kit (Immunochromatography)
Isatifikethi
CE
I-Epidemiology
I-Dengue fever sisifo esosulelayo esibangelwa kukulunywa ziingcongconi zabasetyhini ezithwele intsholongwane yedengue (DENV), ngokusasazeka ngokukhawuleza, izehlo eziphezulu, ukuchaphazeleka okuxhaphakileyo, kunye nokufa okuphezulu kwiimeko ezimandundu..
Phantse abantu abazizigidi ezingama-390 ehlabathini lonke bosulelwa yidengue fever nyaka ngamnye, abantu abazizigidi ezingama-96 abachatshazelwa sesi sifo kumazwe angaphezu kwama-120, awona mandundu eAfrika, eMerika, kuMzantsi-mpuma weAsia nakwiNtshona yePasifiki. Njengoko ukufudumala kwehlabathi kusanda, umkhuhlane wedengue ngoku unwenwela kwimimandla epholileyo kunye nebandayo kunye nokuphakama okuphezulu, kwaye ukuxhaphaka kwe-serotypes kuyatshintsha. Kwiminyaka yakutshanje, imeko yesifo somkhuhlane wedengue imbi kakhulu kuMzantsi Pasifiki, eAfrika, eMzantsi Melika, kumazantsi e-Asiya kunye nakuMzantsi-mpuma Asia, kwaye ibonisa amanqanaba ahlukeneyo okunyuka kosulelo lwe-serotype, indawo yokuphakama, amaxesha onyaka, izinga lokusweleka kunye nenani losulelo.
Idatha esemthethweni ye-WHO ngo-Agasti ka-2019 ibonise ukuba kukho malunga ne-200,000 yeemeko ze-dengue fever kunye nokusweleka kwe-958 kwiiPhilippines. IMalaysia iqokelele ngaphezulu kwe-85,000 yeemeko zedengue phakathi ku-Agasti ka-2019, ngelixa iVietnam yayiqokelele amatyala angama-88,000. Xa kuthelekiswa nexesha elifanayo ngo-2018, inani linyuke ngokuphindwe kabini kumazwe omabini. I-WHO iye yayigqala idengue fever njengengxaki enkulu yempilo yoluntu.
Le mveliso ikhawuleza, kwisiza kunye nekhithi echanekileyo yokufumanisa intsholongwane yedengue i-NS1 antigen kunye ne-IgM/IgG ye-antibody. I-antibody ethile ye-IgM ibonisa ukuba kukho usulelo lwakutsha nje, kodwa uvavanyo lwe-IgM olungenayo alubonisi ukuba umzimba wawosulelekile. Kukwayimfuneko ukubona izilwa-buhlungu ze-IgG ezithile ezinesiqingatha sobomi obude kunye nomxholo ophezulu wokuqinisekisa ukuxilongwa. Ukongeza, emva kokuba umzimba usulelekile, i-antigen ye-NS1 ibonakala kuqala, ngoko ke ukufunyaniswa kwangaxeshanye kwentsholongwane ye-dengue NS1 antigen kunye ne-IgM kunye ne-IgG antibodies inokuxilonga ngokufanelekileyo ukuphendula komzimba kwi-pathogen ethile, kwaye le kiti yokufumanisa i-antigen-antibody edibeneyo inokwenza ukuxilongwa kwangaphambili kunye nokuhlolwa kwinqanaba lokuqala losulelo lwe-dengue, ukuphuculwa kwexesha losulelo lwe-dengue kunye nokuphucula i-dengue ixesha elifutshane kunye nokuphucula i-dengue.
Iiparamitha zobuGcisa
| Ummandla ekujoliswe kuwo | Intsholongwane yeDengue NS1 antigen, IgM kunye ne-IgG antibodies |
| Ubushushu bokugcina | 4℃-30℃ |
| Uhlobo lwesampuli | Iserum yomntu, iplasma, igazi le-venous kunye negazi lencam yomnwe |
| Beka ubomi kwishelufa | Iinyanga ezili-12 |
| Izixhobo ezincedisayo | Ayifuneki |
| Izinto ezisetyenziswayo ezongezelelweyo | Ayifuneki |
| Ixesha lokubona | 15-20 imiz |
| Ukuchaza ngokuthe ngqo | Yenza uvavanyo lwe-cross-reactivity ngentsholongwane yeencephalitis yaseJapan, intsholongwane yeencephalitis yamahlathi, umkhuhlane we-hemorrhagic kunye ne-thrombocytopenia syndrome, i-Xinjiang hemorrhagic fever, i-hantavirus, intsholongwane ye-hepatitis C, intsholongwane yomkhuhlane A, intsholongwane yomkhuhlane B, akukho-reactivity efunyenweyo. |
Ukuhamba komsebenzi
●Igazi le-venous (iSerum, iPlasma, okanye igazi elipheleleyo)
●Igazi leminwe
●Funda isiphumo (imizuzu eyi-15-20)
